MarketInOut Stock Screener Log In | Sign Up

Fortrea Holdings Inc

NASDAQ • Healthcare • Biotechnology • Quote as of 10/30/2026
Fortrea Holdings Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization2,054.49 mln
Float95.53 mln
Earnings Date03/15/2027

Piotroski F-Score

5 / 9
Neutral

Beneish M-Score

-3
Likely reliable

1-Year Forecast

22.62
Modest upside

Relative Strength

23 / 100
Significantly lagging

Debt / Equity

2.10
Very high leverage

Pre-Tax Margin

-2%
Barely loss-making

Business Description

Fortrea Holdings Inc. is a global research company that helps pharmaceutical, biotechnology, and medical device firms develop and bring their products to market. Founded in 2023 and based in Durham, North Carolina, the company supports the full journey of a product's development ? from early laboratory studies and clinical trials to regulatory approval and post-market monitoring. Fortrea also advises clients on strategy, market access, and the real-world performance of their products once launched.

Key Fundamentals

EPS-0.73
ROE-12.60
RPS28.31
ROIC1.92
ROA-2.53
Interest Cover0.55
EBITDA, mln108
EV / EBITDA27.93
EV / EBIT103
Revenue, mln2,667
EV / Revenue1.13

Quote Details

Last 21.29
Change -1.85 (-7.99%)
Open 23.30
Volume 2,872,094
Turnover 61,146,884
Average Volume 2,048,919

Financial Ratios

Pre-Tax Profit Margin-2
Leverage Ratio5.14
Current Ratio0.97
Price / Book3.86
Price / Cash Flow13.01
Price / Free Cash Flow12.01
Debt / Equity2.10
Price / Sales0.76
PEG Ratio0.34

Financial Strength

Altman Z-Score0.82
Piotroski F-Score 5 / 9
Beneish M-Score-3
1-Year Target Price22.62
Short Ratio4.32
Short % of Float9.32

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -9.9% 10 / 100   
1 Month 9.74% 91 / 100   
2 Months 10.89% 88 / 100   
6 Months 74.79% 98 / 100   
1 Year 104% 97 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog